BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 11257619)

  • 21. An immunohistochemical study of normal endometrial stroma and endometrial stromal neoplasms. Evidence for smooth muscle differentiation.
    Franquemont DW; Frierson HF; Mills SE
    Am J Surg Pathol; 1991 Sep; 15(9):861-70. PubMed ID: 1719832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgelin, a Novel Marker of Smooth Muscle Differentiation, Effectively Distinguishes Endometrial Stromal Tumors from Uterine Smooth Muscle Tumors.
    Tawfik O; Rao D; Nothnick WB; Graham A; Mau B; Fan F
    Int J Gynecol Obstet Reprod Med Res; 2014 Sep; 1(1):26-31. PubMed ID: 26023684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
    Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
    Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus.
    Busca A; Gulavita P; Parra-Herran C; Islam S
    Int J Gynecol Pathol; 2018 Jul; 37(4):372-378. PubMed ID: 28700435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific but variable expression of h-caldesmon in leiomyosarcomas: an immunohistochemical reassessment of a novel myogenic marker.
    Hisaoka M; Wei-Qi S; Jian W; Morio T; Hashimoto H
    Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):302-8. PubMed ID: 11759055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype.
    Oliva E; Clement PB; Young RH
    Adv Anat Pathol; 2000 Sep; 7(5):257-81. PubMed ID: 10976906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
    Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J
    Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myxoid endometrial stromal sarcoma of the uterus.
    Kasashima S; Kobayashi M; Yamada M; Oda Y
    Pathol Int; 2003 Sep; 53(9):637-41. PubMed ID: 14507323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H-caldesmon expression in myofibroblastoma of the breast: evidence supporting the distinction from leiomyoma.
    Magro G; Gurrera A; Bisceglia M
    Histopathology; 2003 Mar; 42(3):233-8. PubMed ID: 12605642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Images in pathology. Endometrial stromal sarcoma with hyalinizing giant rosettes and separate leiomyoma with palisading nuclei in the same uterus.
    Cady FM; Kuhn E; Holt JB
    Int J Surg Pathol; 2006 Oct; 14(4):326-7. PubMed ID: 17041196
    [No Abstract]   [Full Text] [Related]  

  • 31. Metastatic low-grade endometrial stromal sarcoma of uterus presenting as a primary pancreatic tumor: case presentation and literature review.
    McCarthy AJ; Clarke BA; McGilvray I; Dickson BC; Khalili K; Chetty R
    Diagn Pathol; 2019 Apr; 14(1):30. PubMed ID: 31010432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mesenchymal uterine tumors. Leiomyomas].
    Lax S
    Pathologe; 2009 Jul; 30(4):274-83. PubMed ID: 19495761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the Immunohistochemical ZEB1 Expression in Uterine Mesenchymal Neoplasms.
    Çelik M; Çelik ZE
    Int J Surg Pathol; 2022 Aug; 30(5):520-527. PubMed ID: 34994578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract.
    Coco DP; Hirsch MS; Hornick JL
    Am J Surg Pathol; 2009 Dec; 33(12):1795-801. PubMed ID: 19950405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical staining characteristics of canine gastrointestinal stromal tumors.
    LaRock RG; Ginn PE
    Vet Pathol; 1997 Jul; 34(4):303-11. PubMed ID: 9240839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus.
    Wang L; Felix JC; Lee JL; Tan PY; Tourgeman DE; O'Meara AT; Amezcua CA
    Gynecol Oncol; 2003 Aug; 90(2):402-6. PubMed ID: 12893208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
    Srodon M; Klein WM; Kurman RJ
    Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine Endometrial Stromal Tumors With Limited Infiltration and Unusual Patterns of Smooth Muscle/Leiomyomatous Differentiation: A Report of 2 Cases Recapitulating Leiomyoma Variants.
    Swanson AA; Huang Y; Bell DA; Schoolmeester JK
    Int J Gynecol Pathol; 2022 Jul; 41(4):e8-e10. PubMed ID: 34166281
    [No Abstract]   [Full Text] [Related]  

  • 40. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.
    Oliva E; Clement PB; Young RH
    Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.